A significant discovery in algal synthetic biology reveals that promoter strength is not an intrinsic property but is heavily influenced by the specific terminator pairing used in the genetic construct. This breakthrough, emerging from intensive research into the marine microalga Nannochloropsis ,
A comparative analysis using human blood cells revealed that these charge-switching lipids were the only delivery vehicles that did not provoke an immune response. This finding addresses the primary hurdle for wider medical application that has persisted since mRNA technology gained global fame:
The appointment of industry veterans from Bristol Myers Squibb and Iovance Biotherapeutics highlights a major transition toward clinical-stage operations for cell therapy developers. This leadership influx comes at a pivotal moment for Link Cell Therapies as it progresses into the Phase I clinical
Raw material imports for medicine currently account for $749 million in annual spending, representing more than half of the country's total medicinal foreign-exchange costs. This financial burden has catalyzed a strategic pivot toward domestic biotechnology, as the nation seeks to insulate its
In the vast, scorched expanse of the Algerian hamada, where the horizon is often obscured by swirling silts and the sun beats down with unforgiving intensity, an unlikely beacon of scientific progress has taken root. The laboratory manages a consistent catalog of 15 to 20 different medications,
Supply chain functions in the life sciences sector frequently lag behind other departments because sustainability data is not yet integrated into daily financial decision-making. Impact Stewards, a leading healthcare consultancy, has addressed this critical gap by launching the Sustainable Supply
